MAPT and Alzheimer disease: We previously reported that a combination of neuropathologic variables (immunostaining for phospho-Tau, TDP-43, HLA-DR:Iba1 ratio, and microvascular lesion count plus a summary score of vascular pathologies) together accounted for 18% of the variance in psychosis risk in AD (15).